IRF3 and neoplasm: It has been reported that the difference in rNDV infectivity between tumor cells and normal cells is responsive to IFN-β [15], the gene expression of RIG-I, IRF-3, IRF-7, and IFN-β before infection [16] or the RIG-I gene and the receptor of type I IFN expression [17].